Search

The Public Health Agency of Sweden compiles, develops and disseminates knowledge to support health promotion and preventive health work, in areas such as mental health, sexual health and lifestyle.

This report describes epidemiological and virological surveillance results for the 2023-2024 influenza season in Sweden. Data are also compared to previous influenza seasons.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The most important task within the area of infection control is preventing infections from spreading and healthcare-associated infections from emerging. As the problem of resistance increases, good infection control becomes a means of preventing antibiotic resistance from spreading.

The main role of The Public Health Agency of Sweden in regard to communicable diseases control is that of coordination and provision of knowledge and guidelines. The operative responsibility on the other hand lies at the regional level with the County Medical Officers. Providers of health and

Our mission is to follow-up, evaluate and disseminate knowledge, and to provide supervisory guidance on environmental health.

Daily cigarette smoking has decreased in Sweden since the 1980s. This decrease coincides with the broad tobacco prevention efforts that have been carried out during the same period.

The Public Health Agency of Sweden is an independent public authority under the Swedish Government. We work to ensure good public health and to ensure that the population is protected against communicable diseases and other health threats.

The Public Health Agency of Sweden is tasked with monitoring, reporting and actively participating in public health work within the EU and internationally. Cooperation takes place primarily through the various EU institutions, the World Health Organisation (WHO), and other UN bodies within the

The report presents results from a pilot test of Tailoring Immunization Programmes (TIP), a method developed by WHO/Europe to identify barriers and motivating factors to MMR vaccination in communities with low coverage in Sweden.